Make an Appointment
-
INTEGRIS Medical Group3330 NW 56th Street, Suite 500, Oklahoma City, OK 73112 map
Dr. Polan will begin working at the INTEGRIS Medical Group on May 31, 2019.
OU Medicine
Published on Jul 10, 2018
INTEGRIS Medical Group
Accepting New Patients?
Yes, Dr. Michelle B. Polan is accepting new patients at this office.
Phone
Fax
(405) 713-7064
Address
3330 NW 56th Street, Suite 500, Oklahoma City, OK 73112
Office Details
Insurance Accepted
- Other
Bio
Dr. Michelle Polan graduated from Gdansk Medical Academy in 1989 before completing a residency in Radiation Oncology at Oncology Center in Bydgoszcz, Poland from 1990 to 1993. She then completed a fellowship in Radiation Oncology at Oncology Center in Bydgoszcz, Poland from 1993 to 1996.
Dr. Polan has one office in Oklahoma where she specializes in Medical Genetics.
Specialty
-
Medical Genetics
Dr. Polan is trained to provide care for hereditary diseases through preventive medicine. Dr, Polan makes diagnoses and crafts personalized treatment plans for those suffering from all types of genetic disorders, especially those that are hereditary or congenital. As a medical geneticist, Dr. Polan relies on preventive and predictive medicine to provide the most useful treatment options for patients and their families.
Education & Training
Medical School
-
Gdansk Medical Academy
MD • 1989
Residencies
-
Oncology Center in Bydgoszcz, Poland
Residency in Radiation Oncology • 1990 - 1993 -
University of Medicine and Dentistry of New Jersey • Newark, NJ
Residency in Pediatrics • 2008 - 2011 -
Nationwide Children’s Hospital • Columbus, OH
Residency in Medical Genetics • 2011 - 2013
Fellowships
-
Oncology Center in Bydgoszcz, Poland
Fellowship in Radiation Oncology • 1993 - 1996 -
Children’s Hospital of Pittsburgh of UPMC • Pittsburgh, Pennsylvania
Fellowship in Medical Biochemical Genetics • 2013 - 2014
Languages Spoken
- English
- Polish
Links & Social Media
Latest Medical Genetics News
-
Opioids Exact Another Toll on Newborns: Smaller HeadsDennis Thompson, HealthDay Reporter, Dec 10, 2018 at 9:00 AM
-
Many Americans Unaware of Promise of Targeted, 'Personalized' Medicine: PollDennis Thompson, HealthDay Reporter, Dec 6, 2018 at 9:00 AM
-
Gene Therapy for Sickle Cell Takes Another Step ForwardAmy Norton, HealthDay Reporter, Dec 4, 2018 at 2:00 PM